Disclosures for "Post-traumatic Epilepsy Timing and Treatment Response in Young Patients with Abusive Head Trauma"
-
The institution of Dr. Messer has received research support from Ultragenyx Pharmaceutical Inc. Dr. Messer has a non-compensated relationship as a Chair of the Pediatric Neurology Specialty Steering Board with Epic that is relevant to AAN interests or activities. Dr. Messer has a non-compensated relationship as a Member of the AAN Quality Informatics Subcommittee with American Academy of Neurology that is relevant to AAN interests or activities.
-
Author has nothing to disclose
-
Amy Connery has nothing to disclose.